Science Pool

Development of Potential PET Ligand for Imaging Mutant Huntingtin Aggregates

Posted by Evotec on Sep 13, 2021 8:06:10 PM

Mutant huntingtin (mHTT) forms protein aggregates characteristic of Huntington's Disease pathology.

In this publication, we focus on:

  • a background to Huntington's Disease including the mutant huntingtin gene (mHTT)
  • a discussion of the benefits of sensitive biomarkers to monitor disease progression
  • the discovery of an mHTT aggregate-specific PET ligand suitable for live brain imaging

LEARN MORE

Tags: Neuroscience, Articles & Whitepapers, In vivo Pharmacology

Pharmacological Characterization of Mutant Huntingtin Aggregate-Directed PET Imaging Tracer Candidates

Posted by Evotec on Sep 13, 2021 8:03:47 PM

Huntington's Disease is caused a mutation in the huntingtin (mHTT) gene which codes for the huntingtin (HTT) protein.

In this publication, we focus on:

  • a background to link between Huntington's Disease and the mutant huntingtin gene (mHTT)
  • the development of PET tracers for imaging mHTT aggregates
  • characterisation of these PET tracers including pharmacological investigation of their binding affinities and selectivity

LEARN MORE

Tags: Neuroscience, Articles & Whitepapers, In vitro Biology, In vivo Pharmacology

ELRIG Pharmaceutical Flow Cytometry & Imaging 2021

Posted by Evotec on Sep 10, 2021 9:39:13 AM

Date: 30th November - 1st December 2021

Location: Circle Square, Oxford Road, Manchester

Attendee: Oksana Nikolayenko

Learn more about ELRIG Pharmaceutical Flow Cytometry & Imaging 2021

Tags: Events, Cyprotex

World Antiviral Congress 2021

Posted by Evotec on Sep 10, 2021 9:28:10 AM

Date: 30th November - 02nd December 2021

Location: Loews Coronado Bay Resort, San Diego

Attendee: David Cerny

Learn more about World Antiviral Congress 2021

Tags: Events, Cyprotex

Pharmacokinetic Prediction Fact Sheet

Posted by Evotec on Sep 9, 2021 5:52:45 PM

Learn more about human pharmacokinetic prediction including:

  • background information on the predictive model
  • in vitro ADME data and structural data requirements for PK prediction
  • data delivered for the PK prediction
  • validation data for the predictive model
DOWNLOAD

Tags: Fact Sheets, ADME/DMPK, Modelling and Simulation

New York Society of Cosmetics Chemists Suppliers' Day 2021

Posted by Evotec on Sep 7, 2021 2:39:04 PM

Date: 10th – 12th November 2021

Location: Jacob K. Javits Convention Centre, New York City

Booth Number: Level 1, Booth 941

Attendee: Ralf Geiben Lynn

Learn more about New York Society of Cosmetics Chemists Suppliers' Day 2021

Tags: Events, Cyprotex

Brain Tissue Binding Fact Sheet

Posted by Evotec on Sep 1, 2021 3:17:35 PM

Learn more about the brain tissue binding assay including:

  • Background information
  • Assay details and protocol summary
  • Data generated in the brain tissue binding assay
DOWNLOAD

Tags: Fact Sheets, ADME/DMPK

Cytochrome P450 Time Dependent Inhibition (IC50 Shift) Fact Sheet

Posted by Evotec on Sep 1, 2021 3:13:19 PM

Learn more about the cytochrome P450 time dependent inhibition (CYP TDI) IC50 shift assay including:

  • Background information
  • Assay details and protocol summary
  • Data generated in the CYP TDI IC50 shift assay
DOWNLOAD

Tags: Fact Sheets, ADME/DMPK

Chronic Exposure Nephrotoxicity Assay Fact Sheet

Posted by Evotec on Sep 1, 2021 3:10:26 PM

Learn more about our chronic exposure nephrotoxicity assay including:

  • Background information
  • Assay details and protocol summary
  • Data generated in the chronic exposure nephrotoxicity assay
DOWNLOAD

Tags: Fact Sheets, Toxicology & Safety

Blood Binding Fact Sheet

Posted by Evotec on Sep 1, 2021 3:09:22 PM

Learn more about the whole blood binding assay including:

  • Background information
  • Assay details and protocol summary
  • Data generated in the whole blood binding assay
DOWNLOAD

Tags: Fact Sheets, ADME/DMPK